Keloids. A fibroproliferative disorder of unknown etiology;Keloide. Eine dermale fibroproliferative erkrankung unbekannter ursache

Hautarzt

Volumn 53, Issue 8, 2002, Pages 515-523

  Kronenwett, Ralf ^a   Gräf, Thorsten ^a   Nedbal, Wolfgang ^b   Weber, Markus ^a   Steidl, Ulrich ^a   Rohr, Ulrich Peter ^a   Möhler, Thomas ^c   Haas, Rainer ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b A3D GmbH   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Keloid; Scars; SMAD; TGF

Indexed keywords

ALLANTOIN; BLEOMYCIN; COLLAGENASE; CONNECTIVE TISSUE GROWTH FACTOR; CONTRACTUBEX; CORTICOSTEROID; CYTOKINE; DERMATOLOGICAL AGENT; FLUOROURACIL; HEPARIN; INTEGRIN; INTERLEUKIN 1; KELOFIBRASE; ONION EXTRACT; PLASMIN; PLATELET DERIVED GROWTH FACTOR; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

BENIGN TUMOR; CARBON DIOXIDE LASER; CREAM; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; EXTRACELLULAR MATRIX; FIBROBLAST; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; KELOID; NEODYMIUM LASER; PATHOGENESIS; REVIEW; SCAR FORMATION; SKIN TUMOR;

CELL DIVISION; FIBROBLASTS; HUMANS; KELOID; SKIN;

EID: 0036934384     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-001-0316-6     Document Type: Review

References (86)

1. Breasted JH (1930) The Edwin Smith surgical papyrus, Vol 1. Hieroglyphic translation and commentary. University of Chicago Press, Chicago, pp 403-406
2. Alibert JLM (1917) Quelques recherches sur les cheloides. Mem Soc Médicale d'Émulation: 744
3. Murray SC (1993) Scars and keloids. Dermatol Clin 11:697-707
4. Nemeth AJ (1993) Keloids and hypertrophic scars. J Dermatol Surg Onc 19:738-746
5. Davies DM (1985) Scars, hypertrophic scars and keloids. Plast Reconstr Surg 290:1056-1058
6. Koonin AJ (1964) The etiology of keloids: a review of the literature and a new hypothesis. South Afr Med J 38:913-914
7. Cosman B, Crikelair F, Ju MC, Gaulin JC, Lattes R (1961) The surgical treatment of keloids. Plast Reconstr Surg 27:335-345
8. Oluwasanmi JO (1974) Keloids in the African. Clin Plast Surg 1:179-195
9. Dustan HP (1995) Does keloid pathogenesis hold the key to understanding black/white differences in hypertension severity? Hypertension 26:858-862
10. Cohen IK, Peacock EE Jr (1990) Keloids and hypertrophic scars. Plastic Surg 1:732-746
11. Murray JC, Pollack SV, Pinnel SR (1981) Keloids: a review. J Am Acad Dermatol 4:461-470
12. Stucker FJ, Shaw GY, (1992) An approach to management of keloids. Arch Otolaryngol Head Neck Surg 118:63-67
13. Calnan JS, Copenhagen HJ (1967) Autotransplantation of keloid in man. Br J Surg 54:330-335
14. Chau D, Mancoll JS, Lee S, Zhao J, Philipps LG, Gittes GK, Longaker MT (1998) Tamoxifen downregulates TGFβ production in keloid fibroblasts. Ann Plast Surg 40:490-493
15. Rossi A, Bozzi M (1989) HLA and Keloids: antigenic frequency and therapeutic response. G Ital Dermatol Venereol 124:341-344
16. Teofoli P, Barduagni S, Ribuffo M, Campanella A, De Pita'O, Puddu P (1999) Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J Dermatol Sci 22:31-37
17. Messadi DV, Le A, Berg S, Jewett A, Wen Z, Kelly P, Bertolami CN (1999) Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Repair Regen 7:511-517
18. Sayah DN, Soo C, Shaw WW et al. (1999) Down-regulation of apoptosis-related genes in keloid tissues. J Surg Res 87:209-216
19. Kazeem AA (1988) The immunological aspects of keloid tumor formation. J Surg Oncol 38:16-18
20. Cohen IK, McCoy BJ, Mohanakumar T, Diegelmann RF (1979) Immunoglobin, complement and histocompatibility antigen studies in keliod patients. Plast Reconstr Surg 63:689-695
21. Kischer CW, Shetlar MR, Shetlar CL, Chrapil M (1983) Immunoglobulins in hypertrophic scars and keloids. Plast Reconstr Surg 71:821-825
22. Kelly AP (1988) Keloids. Dermatol Clin 6:413-424
23. Clore JN, Cohen IK, Diegelmann RF (1979) Quantitative assay of types I and III collagen synthesized by keloid biopsies and fibroblasts. Biochem Biophys Acta 586:384-390
24. Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garber WL (1994) Morphological and immunochemical differences between keloid and hypertrophic scars. Am J Pathol 145:105-113
25. Tredget EE, Nedelec B, Scott PG, Ghahary A (1997) Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 77:701-730
26. Appleton I, Brown NJ, Willoughby DA (1996) Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. Am J Pathol 149:1441-1447
27. Kischer CW, Shetlar MR (1974) Collagen and mucopolysaccharides in the hypertrophic scar. Connect Tissue Res 2:205-213
28. Craig P (1973) Collagenase activity in cutaneous scars. Hand 5:239-246
29. Abergel RP, Pizzurro D, Meeker CA et al. (1985) Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblasts cultures. J Invest Dermatol 84:384-390
30. Werb Z (1997) ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442
31. Singer AJ, Clark RAF (1999) Cutaneous wound healing. NEJM 341:738-746
32. Eckes B, Zigrino P, Kessler D, Holtkötter O, Shephard P, Mauch C, Krieg T (2000) Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol 19:325-332
33. Akagi A, Tajima S, Ishibashi A, Yamaguchi M, Nagai Y (1999) Expression of Typ XVI collagen in human skin fibroblasts: enhanced expression in fibrotic skin diseases. J Invest Dermatol 113:246-250
34. Brinckmann J, Notbohm H, Tronnier M et al. (1999) Overhydroxylation of lysyl residues is the initial step for altered collagen crosslinks and fibril architecture in fibrotic skin. J Invest Dermatol 113:617-621
35. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25
36. Eble JA, Kühn K (1997) Integrin-ligand interaction. Springer Press, New York
37. Kischer CW, Wagner HN Jr, Pindur J, Holubec H, Jones M, Ulreich JB, Scuderi P (1989) Increased fibronectin production by cell lines from hypertrophic scar and keloid. Connect Tissue Res 23:279-288
38. Babu M, Diegelmann R, Oliver N (1989) Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 9:1642-1650
39. Friedmann DW, Boyd CD, Mackenzie JW, Norton P, Olson RM, Deak SB (1993) Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res 55:214-222
40. Russel SB et al. (1995) Glucocorticoid regulation of elastin synthesis in human fibroblasts: Down-regulation in fibroblasts from normal dermis but not from keloids. J Invest Dermatol 104:241-245
41. Bell E, Ivarrson B, Merrill C (1979) Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci 76:1274-1278
42. Mauch C, Kozlowska E, Eckes B, Krieg T (1992) Altered regulation of collagen metabolism in scleroderma fibroblasts grown within three-dimensional collagen gels. Exp Dermatol 1:185-190
43. Ravanti L, Kähäri VM (2000) Matrix metalloproteinases in wound repair. Int J Mol Med 6:391-407
44. Declerk P (1993) Plasminogen activator inhibtor-1: Biochemical, structural and functional studies. Verh K Acad Geneeskd Belg 55:457-473
45. Lyons RM, Gentry LE, Purchio AF, Moses HL (1990) Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol 110:1361-1367
46. Roberts AB (1998) Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24:111-119
47. Ladin D (1995) The art and science of wound care. Plast Reconstr Surg 96:748
48. Craig RD, Schofield JD, Jackson DS (197S) Collagen biosynthesis in normal and hypertrophic scars and keloid as a function of the duration of the scar. Br J Surg 62:741-744
49. Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME, Laug WE (1996) Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 106:1007-1011
50. Montgomery AM, De Clerk YA, Langley KE, Reisfeld RA, Mueller BM (1993) Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Res 53:693-700
51. Ladin DA, Hou Z, Patel D, McPhail M, Olson JC, Saed GM, Fivenson DP (1998) PS3 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen 6:28-37
52. Shah M, Foremann DM, Ferguson MW (1994) Neutralising antibody to TGFβ-1,-2 reduces cutaneous scarring in adult rodents. J Cell Sci 107:1137-1157
53. Shah M, Foremann DM, Ferguson MW (1995) Neutralisation of TGFβ-1 and TGFβ-2 or exogenous addition of TGFβ-3 to cutaneous rat wounds reduces scarring. J Cell Sci 108:985-1002
54. Peltonen J, Hsiao LL, Jaakkola S et al. (1991) Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol 97:240-248
55. Lee T, Chin G, Kim WJH, Gittes GK, Longaker MT (1999) Differential expression of TGF-beta 1, beta 2 and beta 3 in keloid fibroblasts. Ann Plast Surg 43:179-184
56. Massague J (1996) TGFbeta signaling: receptors, transducers, and MAD proteins. Cell 85:947-950
57. Kim WJH, Gittes GK, Longaker MT (1998) Signal transduction in wound pharmacology. Arch Pharmacol Res 21:487-495
58. Derynck R (1998) SMAD proteins and mammalian anatomy. Nature 393:737-739
59. Massague J (1996) Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cancer Surv 27:41-64
60. Tuan TL, Nichter LS (1998) The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4:19-24
61. Harper RA (1989) Keloid fibroblast in culture: abnormal growth behaviour and altered response to the epidermal growth factor. Cell Biol Int Rep 13:325-335
62. Igarashi A, Okochi H, Bradham DM, Grotendorst DR (1993) Regulation of CTGF gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4:637-645
63. Kischer CW, Shetlar MR, Shetlar CL (1975) Alteration of hypertrophic scars induced by mechanical pressure. Arch Dermatol 111:60-64
64. Haq MA, Haq A (1990) Pressure therapy in treatment of hypertrophic scar, burn and keloid: the Kenyan experience. East Afr Med J: 785-791
65. Snyder GB (1974) Button compression for keloids of the lobule. Br J Plast Surg 27:186-187
66. Farrior RT, Stambaugh KI (1989) Keloids and hyperplastic scars. In: Thomas JR, Holt GR (eds) Facial scars, revisions, and camouflage. CV Mosby, St Louis, pp 211-228
67. Murray JC, Pinnel SR (1992) Keloids and excessive dermal scarring. In: Cohen IK, Diegelman RF, Lindblod WS (eds) Wound healing: biochemical and clinical aspects. WB Saunders, Philadelphia, pp 500-509
68. Gold MH (1994) A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol 30:506-507
69. Sawada Y, Sone K (1992) Hydration and occlusion treatment for hypertrophic scars and keloids. Br J Plast Surg 45:599-603
70. Bieley HC, Berman B (1996) Effects of water-impermeable, non-silicone-based occlusive dressing on keloids. J Am Acad Dermatol 35:113-114
71. Goslen JB (1989) The role of steroids in preventing scar formation. In: Thomas JR, Holt GR (eds) Facial scars, revisions, and camouflage. CV Mosby, St. Louis, pp 83-97
72. Lawrence WT (1991) In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg 27:164-178
73. Conway H, Gillette RW, Smith JW, Findley A (1960) Differential diagnosis of keloids and hypertrophic scars by tissue culture technique with notes on the therapy of keloids by surgical excision and Decadron. Plast Reconstr Surg 25:117-121
74. Espana A, Solano T, Quintanilla E (2001) Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 27:23-27
75. Fitzpatrick RE (1999) Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 25:224-232
76. Majewski S, Chadzynska M (1988) Effects of heparin, allantoin and cepae extract on the proliferation of keloid fibroblasts and other cells in vitro. Dermatol Monatsschr 174:106-129
77. Zouboulis CC, Blume U, Buttner P et al. (1993) Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol 129:1146-1151
78. Rusciani L, Rossi G, Bono R (1993) Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol 19:529-534
79. Sherris DA, Larrabee WF, Murakami CS (1995) Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am 28:1057-1068
80. Alster TS, Williams C (1995) Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet 345:1198-1200
81. Sherman R, Rosenfeld H (1988) Experience with the Nd: YAG laser in the treatment of keloid scars. Ann Plast Surg 24:231-233
82. Henderson DL, Cromwell TA, Mes LG (1984) Argon and carbon dioxide laser treatment of hypertrophic and keloid scars. Lasers Surg Med 3:271-277
83. Norris JCE (1991) The effect of carbon dioxide laser surgery on the recurrence of keloids. Plast Reconstr Surg 87:44-49
84. Stucker FJ, Shaw GY (1992) An approach to managements of keloids. Arch Otolaryngol Head Neck Surg 118:63-67
85. Henning JPH, Roskam Y, van Gemert MJC (1986) Treatment of keloids and hypertrophic scars with an argon laser. Lasers Surg Med 6:72-75
86. Hellwig S, Raulin C (1999) Gepulste Laser in der Narbenbehandlung. Hautarzt 50:465-469